Garlic: What we know and what we don't know

Archives of Internal Medicine

Volumn 167, Issue 4, 2007, Pages 325-326

  Charlson, Mary ^a   McFerren, Marcus ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; EDITORIAL; FAT INTAKE; FOOD INTAKE; GARLIC; HUMAN; INFECTION; MEDICINAL PLANT; PRIORITY JOURNAL;

GARLIC; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, LDL; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 33847406195     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.4.325     Document Type: Editorial

References (13)

1. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr. 2006;136(3)(suppl):736S-740S.
2. Reuter HD. Allium sativum and Allium ursinum, part 2: pharmacology and medicinal application. Phytomedicine. 1995;2:73-91.
3. Sendl A. Allium sativum and Allium ursinum, part 2: pharmacology and medicinal application. Phytomedicine. 1995;4:323-329.
4. Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med. 2007;167:346-353.
5. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results JAMA. 1982;248:1465-1477.
6. Lawson LD, Gardner CD. Composition, stability, and bioavailability of garlic products used in a clinical trial. J Agric Food Chem. 2005;53:6254-6261.
7. Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem due to the sensitivies of alliinase activity. J Agric Food Chem. 2001;49:2592-2599.
8. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
9. Chan AC. Vitamin E and atherosclerosis. J Nutr. 1998;128:1593-1596.
10. Lau BH. Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr. 2006;136(3)(suppl): 765S-768S.
11. Gonen A, Harats D, Rabinkov A, et al. The antiatherogenic effect of allicin: possible mode of action. Pathobiology. 2005;72:325-334.
12. Budoff M. Aged garlic extract retards progression of coronary artery calcification. J Nutr. 2006;136(3)(suppl):741S-744S.
13. Allison GL, Lowe GM, Rahman K. Aged garlic extract and its constituents inhibit platelet aggregation through multiple mechanisms. J Nutr. 2006;136(3)(suppl):782S-788S.